Acute liver failure in scotland between 1992 and 2009; incidence, aetiology and outcome

QJM: An International Journal of Medicine

Volumn 104, Issue 11, 2011, Pages 945-956

  Bretherick, A D ^a   Craig, D G N ^a   Masterton, G ^a   Bates, C ^a   Davidson, J ^a   Martin, K ^a   Iredale, J P ^b   Simpson, K J ^b  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; CHLORPROMAZINE; CLARITHROMYCIN; CYPROTERONE; DANTROLENE; DICLOFENAC; FLUCLOXACILLIN; NITROFURANTOIN; ONDANSETRON; ORAL CONTRACEPTIVE AGENT; PARACETAMOL; PRAVASTATIN; RIFAMPICIN; SALAZOSULFAPYRIDINE; STAVUDINE; TERFENADINE; TUBERCULOSTATIC AGENT; VALPROIC ACID;

ACUTE LIVER FAILURE; ADOLESCENT; ADULT; AGED; ALCOHOL LIVER DISEASE; ARTICLE; ARTIFICIAL VENTILATION; AUTOIMMUNE HEPATITIS; BUDD CHIARI SYNDROME; CHILD; CHRONIC LIVER DISEASE; CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DISEASE SEVERITY; DRUG DEPENDENCE; DRUG HYPERSENSITIVITY; DRUG OVERDOSE; FEMALE; HEPATIC ENCEPHALOPATHY; HEPATITIS A; HEPATITIS B; HEPATITIS E; HOSPITAL ADMISSION; HOSPITAL DEPARTMENT; HOSPITAL DISCHARGE; HUMAN; IDIOSYNCRATIC DRUG REACTION; INCIDENCE; LIVER INJURY; LIVER ISCHEMIA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PORTAL VEIN THROMBOSIS; PREDICTIVE VALUE; PREGNANCY DISORDER; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RISK FACTOR; SCHOOL CHILD; SCOTTISH LIVER TRANSPLANT UNIT; SEPSIS; SURVIVAL RATE; TREATMENT OUTCOME; UNITED KINGDOM; UNIVERSITY HOSPITAL; WILSON DISEASE;

EID: 84155179207     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcr098     Document Type: Article

References (26)

1. O'Grady JG, Schalm SW, Williams R. Acute liver failure: redefining the syndromes. Lancet 1993; 342:273-5.
2. Lee WM. Acute liver failure. N Engl J Med 1993; 329:1862-72.
3. U.S. Census Bureau. Resident Population Estimates of the United States by Sex, Race, and Hispanic Origin. April 1, 1990 to July 1, 1999, with Short-Term Projection to November 1, 2000. [http://www.census.gov/] Accessed 23 December 2009.
4. Fagan E, Wannan G. Reducing paracetamol overdoses. Brit Med J 1996; 313:1417-8.
5. Simpson KJ, Bates CM, Henderson NC, Wigmore SJ, Garden OJ, Lee A, et al. The utilization of liver transplantation in the management of acute liver failure: comparison between acetaminophen and nonacetaminophen etiologies. Liver Transpl 2009; 15:600-9.
6. Schiodt FV, Atillasoy E, Shakil AO, Schiff ER, Caldwell C, Kowdley KV, et al. Etiology and outcome for 295 patients with acute liver failure in the United States. Liver Transpl 1999; 5:29-34.
7. Ostapowicz G, Fontana RJ, Schiødt FV, Larson A, Davern TJ, Han SHB, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002; 137:947-54.
8. Gow PJ, Jones RM, Dobson JL, Angus PW. Etiology and outcome of fulminant hepatic failure managed at an Australian liver transplant unit. J Gastroenterol Hepatol 2004; 19:154-9.
9. General Register Office for Scotland. Mid-2001 Population Estimates for Health Boards. [http://www.gro-scotland.gov.uk/] Accessed 23 December 2009.
10. O'Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989; 97:439-45.
11. Bernal W, Donaldson N, Wyncoll D, Wendon J. Blood lactate as an early predictor of outcome in paracetamolinduced acute liver failure: a cohort study. Lancet 2002; 359:558-63.
12. Bernal W, Wendon J, Rela M, Heaton N, Williams R. Use and outcome of liver transplantation in acetaminophen-induced acute liver failure. Hepatology 1998; 27: 1050-5.
13. Beer C, Pakravan N, Hudson M, Smith LT, Simpson K, Bateman DN, et al. Liver unit admission following paracetamol overdose with concentrations below current UK treatment thresholds. Q J Med 2007; 100:93-6.
14. Smith IDM, Simpson KJ, Garden OJ, Wigmore SJ. Non-paracetamol drug-induced fulminant hepatic failure among adults in Scotland. Eur J Gastroenterol Hepatol 2005; 17:161-7.
15. Areia M, Romãozinho JM, Ferreira M, Amaro P, Leitão MC. Fulminant hepatic failure: a Portuguese experience. Eur J Gastroenterol Hepatol 2007; 19:665-9.
16. Larson AM, Polson J, Fontana RJ, Davern TJ, Lalani E, Hynan LS, et al. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology 2005; 42:1364-72.
17. Roberts EA, Schilsky ML. A practice guideline on Wilson disease. Hepatology 2003; 37:1475-92.
18. Cook R, Allcock R, Johnston M. Self-poisoning: current trends and practice in a U.K. teaching hospital. Clin Med 2008; 8:37-40.
19. Gorman DR, Bain M, Inglis JHC, Murphy D, Bateman DN. How has legislation restricting paracetamol pack size affected patterns of deprivation related inequalities in self-harm in Scotland? Public health 2007; 121:45-50.
20. Newsome PN, Bathgate A, Henderson NC, MacGilchrist AJ, Plevris JN, Masterton G, et al. Referral patterns and social deprivation in paracetamol-induced liver injury in Scotland. Lancet 2001; 358:1612-3.
21. Craig DGN, Lee A, Hayes PC, Simpson KJ. Review article: the current management of acute liver failure. Aliment Pharmacol Ther 2010; 31:345-58.
22. Schmidt LE, Larsen FS. MELD score as a predictor of liver failure and death in patients with acetaminophen-induced liver injury. Hepatology 2007; 45:789-96.
23. Shakil AO, Kramer D, Mazariegos GV, Fung JJ, Rakela J. Acute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria. Liver Transpl 2000; 6:163-9.
24. Fontana RJ. Acute liver failure including acetaminophen overdose. Med Clin North Am 2008; 92:761-94, viii.
25. Polson J, Lee WM. AASLD position paper: the management of acute liver failure. Hepatology 2005; 41:1179-97.
26. De Silva AN, Muddu AK, Iredale JP, Sheron N, Khakoo SI, Pelosi E. Unexpectedly high incidence of indigenous acute hepatitis E within South Hampshire: time for routine testing? J Med Virol 2008; 80:283-8.